Lesbats J, Brillac A, Reisz J, Mukherjee P, Lhuissier C, Fernandez-Monreal M
Nature. 2025; .
PMID: 40011782
DOI: 10.1038/s41586-025-08629-4.
Anand J, Droby G, Joseph S, Patel U, Zhang X, Klomp J
bioRxiv. 2025; .
PMID: 39975297
PMC: 11838190.
DOI: 10.1101/2025.01.26.634889.
Li D, Geng K, Hao Y, Gu J, Kumar S, Olson A
J Clin Invest. 2024; 135(2.
PMID: 39718828
PMC: 11735103.
DOI: 10.1172/JCI174249.
Pedrosa P, Zhang Z, Nunez-Quintela V, Macias D, Ge J, Denholm M
Cell Death Dis. 2024; 15(11):857.
PMID: 39587064
PMC: 11589828.
DOI: 10.1038/s41419-024-07207-2.
Fernandez-Garcia F, Fernandez-Rodriguez A, Fustero-Torre C, Pineiro-Yanez E, Wang H, Lechuga C
Proc Natl Acad Sci U S A. 2024; 121(36):e2402913121.
PMID: 39186651
PMC: 11388366.
DOI: 10.1073/pnas.2402913121.
Large-Scale Genome-Wide Optimization and Prediction of the Cre Recombinase System for Precise Genome Manipulation in Mice.
Hosur V, Erhardt V, Hartig E, Lorenzo K, Megathlin H, Tarchini B
Res Sq. 2024; .
PMID: 39011108
PMC: 11247941.
DOI: 10.21203/rs.3.rs-4595968/v1.
Large-Scale Genome-Wide Optimization and Prediction of the Cre Recombinase System for Precise Genome Manipulation in Mice.
Erhardt V, Hartig E, Lorenzo K, Megathlin H, Tarchini B, Hosur V
bioRxiv. 2024; .
PMID: 38948742
PMC: 11212873.
DOI: 10.1101/2024.06.14.599022.
Endogenous oncogenic KRAS expression increases cell proliferation and motility in near-diploid hTERT RPE-1 cells.
Hindul N, Abbott L, Adan S, Straatman K, Fry A, Hirota K
J Biol Chem. 2024; 300(6):107409.
PMID: 38796063
PMC: 11234024.
DOI: 10.1016/j.jbc.2024.107409.
pH-responsive targeted nanoparticles release ERK-inhibitor in the hypoxic zone and sensitize free gemcitabine in mutant K-Ras-addicted pancreatic cancer cells and mouse model.
Dutta D, Ray P, De A, Ghosh A, Hazra R, Ghosh P
PLoS One. 2024; 19(4):e0297749.
PMID: 38687749
PMC: 11060587.
DOI: 10.1371/journal.pone.0297749.
Beyond genetics: driving cancer with the tumour microenvironment behind the wheel.
Yuan S, Almagro J, Fuchs E
Nat Rev Cancer. 2024; 24(4):274-286.
PMID: 38347101
PMC: 11077468.
DOI: 10.1038/s41568-023-00660-9.
Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer.
Macaya I, Roman M, Welch C, Entrialgo-Cadierno R, Salmon M, Santos A
Nat Commun. 2023; 14(1):6332.
PMID: 37816716
PMC: 10564741.
DOI: 10.1038/s41467-023-41828-z.
Single-cell RNA sequencing identifies a novel proliferation cell type affecting clinical outcome of pancreatic ductal adenocarcinoma.
Ye B, Wang Q, Zhu X, Zeng L, Luo H, Xiong Y
Front Oncol. 2023; 13:1236435.
PMID: 37601684
PMC: 10433893.
DOI: 10.3389/fonc.2023.1236435.
Mouse models in colon cancer, inferences, and implications.
Kucherlapati M
iScience. 2023; 26(6):106958.
PMID: 37332609
PMC: 10272511.
DOI: 10.1016/j.isci.2023.106958.
Plexin-B1 Mutation Drives Metastasis in Prostate Cancer Mouse Models.
Shorning B, Trent N, Griffiths D, Worzfeld T, Offermanns S, Smalley M
Cancer Res Commun. 2023; 3(3):444-458.
PMID: 36936664
PMC: 10019359.
DOI: 10.1158/2767-9764.CRC-22-0480.
Role of RUNX3 in Restriction Point Regulation.
Lee J, Lee Y, Kim M, Chi X, Kim D, Bae S
Cells. 2023; 12(5).
PMID: 36899846
PMC: 10000377.
DOI: 10.3390/cells12050708.
Cre recombinase microinjection for single-cell tracing and localised gene targeting.
Sendra M, de Dios Hourcade J, Temino S, Sarabia A, Ocana O, Dominguez J
Development. 2023; 150(3).
PMID: 36734327
PMC: 10110498.
DOI: 10.1242/dev.201206.
CDK8 and CDK19 act redundantly to control the CFTR pathway in the intestinal epithelium.
Prieto S, Dubra G, Camasses A, Aznar A, Begon-Pescia C, Simboeck E
EMBO Rep. 2022; 24(2):e54261.
PMID: 36545778
PMC: 10549226.
DOI: 10.15252/embr.202154261.
Characterization of mutant versions of the R-RAS2/TC21 GTPase found in tumors.
Clavain L, Fernandez-Pisonero I, Movilla N, Lorenzo-Martin L, Nieto B, Abad A
Oncogene. 2022; 42(5):389-405.
PMID: 36476833
PMC: 9883167.
DOI: 10.1038/s41388-022-02563-9.
Genomic Landscapes and Hallmarks of Mutant RAS in Human Cancers.
Scharpf R, Balan A, Ricciuti B, Fiksel J, Cherry C, Wang C
Cancer Res. 2022; 82(21):4058-4078.
PMID: 36074020
PMC: 9627127.
DOI: 10.1158/0008-5472.CAN-22-1731.
A New View of Activating Mutations in Cancer.
Nussinov R, Tsai C, Jang H
Cancer Res. 2022; 82(22):4114-4123.
PMID: 36069825
PMC: 9664134.
DOI: 10.1158/0008-5472.CAN-22-2125.